Literature DB >> 26209393

Purpuric herpes zoster in patients in therapy with clopidogrel.

S Veraldi1, F Vaira2, G Nazzaro2.   

Abstract

Clopidogrel is an adenosine diphosphate receptor antagonist used for the prevention of vascular events in patients with atherothrombotic diseases manifested by recent myocardial infarction, ischemic stroke or peripheral arterial disease. Diarrhoea, rash and pruritus are rather common side effects of clopidogrel. Other side effects include epistaxis, nausea, abdominal pain, vomiting, gastritis, gastric and duodenal ulcer. Thrombocytopenia is the most common laboratory abnormality. Leucopenia and neutropenia are rare. We report three cases of purpuric herpes zoster in patients in therapy with clopidogrel. To our knowledge, only one case of haemorrhagic herpes zoster has been published in a patient in therapy with this drug.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clopidogrel; HIV; Haemorrhagic herpes zoster; Herpes zoster; Purpuric herpes zoster

Mesh:

Substances:

Year:  2015        PMID: 26209393     DOI: 10.1016/j.jcv.2015.05.028

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  3 in total

1.  Herpes zoster incognito: an immunohistochemical diagnosis.

Authors:  Gianluca Nazzaro; Stefano Veraldi
Journal:  An Bras Dermatol       Date:  2020-03-19       Impact factor: 1.896

2.  Hemorrhagic herpes zoster with contralateral multidermatomal distribution associated with rivaroxaban: An unusual presentation.

Authors:  Josiah Sowell; Harris Reynolds; John Sowell
Journal:  JAAD Case Rep       Date:  2021-01-17

3.  Four cases of hemorrhagic herpes zoster associated with dabigatran therapy.

Authors:  Stefano Veraldi; Andrea E Beretta; Cristina Beatrice Spigariolo
Journal:  Dermatol Ther       Date:  2022-03-13       Impact factor: 3.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.